tetano
Editor, Senior Moderator
J Pediatric Infect Dis Soc
. 2020 Dec 2;piaa161.
doi: 10.1093/jpids/piaa161. Online ahead of print.
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19
Elizabeth M Anderson[SUP] 1 [/SUP], Caroline Diorio[SUP] 2 3 [/SUP], Eileen C Goodwin[SUP] 1 [/SUP], Kevin O McNerney[SUP] 2 3 [/SUP], Madison E Weirick[SUP] 1 [/SUP], Sigrid Gouma[SUP] 1 [/SUP], Marcus J Bolton[SUP] 1 [/SUP], Claudia P Arevalo[SUP] 1 [/SUP], Julie Chase[SUP] 2 4 [/SUP], Philip Hicks[SUP] 1 5 [/SUP], Tomaz B Manzoni[SUP] 1 [/SUP], Amy E Baxter[SUP] 6 7 [/SUP], Kurt P Andrea[SUP] 6 7 [/SUP], Chakkapong Burudpakdee[SUP] 2 [/SUP], Jessica H Lee[SUP] 2 [/SUP], Laura A Vella[SUP] 6 7 8 [/SUP], Sarah E Henrickson[SUP] 9 [/SUP], Rebecca M Harris[SUP] 10 [/SUP], E John Wherry[SUP] 6 7 [/SUP], Paul Bates[SUP] 1 11 [/SUP], Hamid Bassiri[SUP] 2 8 [/SUP], Edward M Behrens[SUP] 2 4 [/SUP], David T Teachey[SUP] 2 3 [/SUP], Scott E Hensley[SUP] 1 [/SUP]
Affiliations
Abstract
SARS-CoV-2 antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.
Keywords: Antibodies; COVID-19; Multisystem Inflammatory Syndrome in Children (MIS-C); Pediatric; SARS-COV-2.
. 2020 Dec 2;piaa161.
doi: 10.1093/jpids/piaa161. Online ahead of print.
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19
Elizabeth M Anderson[SUP] 1 [/SUP], Caroline Diorio[SUP] 2 3 [/SUP], Eileen C Goodwin[SUP] 1 [/SUP], Kevin O McNerney[SUP] 2 3 [/SUP], Madison E Weirick[SUP] 1 [/SUP], Sigrid Gouma[SUP] 1 [/SUP], Marcus J Bolton[SUP] 1 [/SUP], Claudia P Arevalo[SUP] 1 [/SUP], Julie Chase[SUP] 2 4 [/SUP], Philip Hicks[SUP] 1 5 [/SUP], Tomaz B Manzoni[SUP] 1 [/SUP], Amy E Baxter[SUP] 6 7 [/SUP], Kurt P Andrea[SUP] 6 7 [/SUP], Chakkapong Burudpakdee[SUP] 2 [/SUP], Jessica H Lee[SUP] 2 [/SUP], Laura A Vella[SUP] 6 7 8 [/SUP], Sarah E Henrickson[SUP] 9 [/SUP], Rebecca M Harris[SUP] 10 [/SUP], E John Wherry[SUP] 6 7 [/SUP], Paul Bates[SUP] 1 11 [/SUP], Hamid Bassiri[SUP] 2 8 [/SUP], Edward M Behrens[SUP] 2 4 [/SUP], David T Teachey[SUP] 2 3 [/SUP], Scott E Hensley[SUP] 1 [/SUP]
Affiliations
- PMID: 33263756
- DOI: 10.1093/jpids/piaa161
Abstract
SARS-CoV-2 antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.
Keywords: Antibodies; COVID-19; Multisystem Inflammatory Syndrome in Children (MIS-C); Pediatric; SARS-COV-2.